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INTRODUCTION
Gastric cancer occurs with a high incidence in Asia and is
one of the leading causes of cancer deaths worldwide. Al-
though it is well known that environmental factors such as
dietary habit and Helicobacter pylori infection are associated with
the risk of gastric cancer, host genetic factors may be one of
the critical factors in gastric carcinogenesis.
Cell to cell adhesion plays a critical role in the development
and maintenance of complex differentiated epithelial tissues
and structures in multicellular organisms. Interference with
cell attachment, independence of growth control, and increased
migration have long been implicated during the neoplastic
process (1, 2). The cadherins constitute a large family of cell
membrane glycoproteins involved in the calcium-dependent
cell-cell adhesion molecules (3). The human E-cadherin, so
called CDH1, the major cadherin molecule expressed by epi-
thelial cells, maps to chromosome 16q22 (4) and serves as the
prime mediator of epithelial cell adhesion through homotypic
interactions of its extracellular domain. There are overwhe-
lming genetic data to support the role of E-cadherin as a tu-
mor invasion suppressor in epithelial cells. Structural abnor-
malities and loss of expression of the E-cadherin were shown
to disrupt E-cadherin-mediated intercellular adhesion and are
frequently associated with high tumor grade, infiltrative gro-
wth, and lymph node metastasis in a variety of human malig-
nancies, including diffuse-type gastric cancer, hepatocellular
carcinomas and lobular carcinomas of the breast (5-8). It has
also been shown that loss of E-cadherin expression in a trans-
genic mouse model is associated with the development of inva-
sive carcinoma from well differentiated adenoma (9).
Interestingly, nucleotide variations in DNA sequence, espe-
cially in promoter and protein encoding region of a gene, are
very important to the function and transcriptional efficiency
of the gene (10, 11). The E-cadherin gene encoding E-cadherin
is highly polymorphic, and several diallelic polymorphisms
have been reported. Three of these are in the promoter region
at positions -347, -163, and -160 numbering from the tran-
scription start site, representing G→GA, T→△T, and C→A
transversion, respectively (11, 12). Recently, it has been report-
ed that the polymorphism, located -160 upstream from the
E-cadherin transcription site, showed different transcription-
al binding strength and the transcriptional activity in vitro
(11). Thus, the A allele promoter variant was regarded as a
potential genetic marker that can identify those individuals
at higher risk of gastric cancer. Furthermore, E-cadherin pro-
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A Single Nucleotide Polymorphism in the E-cadherin Gene Promoter 
-160 is Not Associated with Risk of Korean Gastric Cancer
Recently, the -160 C/A polymorphism, located within the regulatory region of E-
cadherin promoter, has been shown to influence E-cadherin transcription by alter-
ing transcription factor binding. We examined the effect of this polymorphism on
risk of gastric cancer and on histological classification of intestinal- and diffuse-type
gastric cancer in 146 normal healthy individuals and 292 Korean gastric cancer
patients. Genomic DNA samples were examined by polymerase chain reaction
(PCR)-single strand conformational polymorphism (SSCP)-sequencing and con-
firmed by restriction fragment length polymorphism (RFLP). Unexpectedly, there
was no significant difference in the genotype frequencies of the polymorphism be-
tween normal control and gastric cancer patients (
2 test, p=0.433). The estimated
odd ratio of C/C to A/A genotype in gastric cancer cases was 1.07 (95% confidence
interval, 0.396-2.870). We also found no evidence for differences in risk for the in-
testinal- and diffuse-type gastric cancer. These results suggest that the -160 C/A
polymorphism of the E-cadherin has no direct effect on the risk of Korean gastric
cancer development and on its histological classification.
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moter polymorphism at position -160 has been associated
with an increased susceptibility to sporadic diffuse-type gas-
tric cancer (13). However, It has been reported that the A allele
was suggested to be protective against gastric cancer in Tai-
wanese (14) and that the -160 promoter polymorphism is not
associated with risk of gastric cancer (15). Thus, it is worth-
while to investigate the genotype specific risk of -160 pro-
moter polymorphism in Korean gastric cancer patients. In the
present study, we examined the effect of this polymorphism
on risk of gastric cancer and on histological classification of
intestinal- and diffuse-type gastric cancer in Korean.
MATERIAL AND METHODS
Samples
A total of 292 paraffin-embedded sporadic gastric carcino-
ma specimens were obtained from College of Medicine, the
Catholic University of Korea. No patient had a family histo-
ry of gastric cancer. Hematoxylin & eosin (H&E)- stained his-
tological sections were reviewed in each case. Gastric carcino-
mas were classified according to the Lauren’s criteria (16): 165
carcinomas were of the intestinal-type and 127 tumors of the
diffuse-type. In addition, 146 healthy individuals were also
included as normal controls in this study. 
DNA extraction
Normal gastric mucosa or lymphocytes were selectively pro-
cured from H&E-stained slides using a 30 G1/2 hypodermic
needle (Becton Dickinson, Franklin Lake, NJ). DNA extrac-
tion was performed by a modified single step DNA extraction
method, as described previously (17).
Allelic analysis
The allele frequencies of -160 promoter polymorphism of
E-cadherin gene were analyzed by polymerase chain reaction
(PCR)-single strand conformational polymorphism (SSCP)
analysis. Genomic DNAs were amplified with the primer cov-
ering the promoter region of the E-cadherin. The primer se-
quences were as follows; forward primer, 5′ -ATCAGAAC-
CGTGCAGGTCCCATAA-3′ and reverse, 5′ -GTTCACC-
TGCCGGCCACAG-3′ . Each PCR was performed under
standard conditions in a 10  L reaction mixture containing 1
L of template DNA, 0.5  M of each primer, 0.2  M of each
deoxynucleotide triphosphate, 1.5  M MgCl2, 0.4 unit of Taq
polymerase, 0.5  Ci of [32P] dCTP (Amersham, Buckingham-
shire, U.K.), and 1  L of 10× buffer. The reaction mixture
was denatured for 1 min at 94℃and incubated for 30 cycles
(denaturing for 40 sec at 94℃, annealing for 40 sec at 60℃,
and extending for 40 sec at 72℃). Final extension was con-
tinued for 5 min at 72℃. After amplification, PCR products
were denatured for 5 min at 95℃ at 1:1 dilution of sample
buffer containing 98% formamide/5 mmol/L NaOH and were
loaded onto a SSCP gel (FMC Mutation Detection Enhance-
ment system; Intermountain Scientific, Kaysville, UT, U.S.A.)
with 10% glycerol. Samples were electrophoresed at 8 W at
room temperature overnight. After electrophoresis, the gels
were transferred to 3 mm Whatman paper and dried, and au-
toradiography was performed with Kodak X-OMAT film
(Eastman Kodak, Rochester, NY, U.S.A.) (Fig. 1A). For the
detection of allele sequence, DNA bands were cut out from
the dried gel, and reamplified for 30 cycles using the same
primer set. Sequencing of the PCR products was carried out
using the cyclic sequencing kit (Perkin-Elmer, Foster City,
CA, U.S.A.) according to the manufacturer’s recommendation
(Fig. 1B, C). We also performed PCR-restriction fragment
length polymorphism (RFLP) to confirm the PCR-SSCP re-
sults. After amplification with the same primer set, the PCR
products were digested with 5 U of restriction enzyme HphI
or AflIII at 37℃for 16 hr. The C allele had an HphI recogni-
tion site, whereas the A allele created an AflIII site. DNA
fragments then were eletrophoresed on a 10% polyacrylamide
gel (Fig. 1D).
Statistical analysis
The chi-square test for association was used to test difference
of the genotype frequencies between normal controls and gas-








































Fig. 1. Genotype analysis at -160 promoter polymorphic site of E-
cadherin by SSCP-sequencing and RFLP. SSCP band patterns of
heterozygote with C/A and homozygote with A/A and C/C (A); Se-
quencing showing homozygotes with A/A (B) and C/C (C); the PCR
products were digested with AflIII restriction endonuclease. If the
recognition site was present, amplified DNA (151 bp in size) pro-
duced two fragments, 89 bp and 62 bp (D).CDH1 Polymorphism in Korean Gastric Cancer 503
genotype specific risks were estimated as odds ratios with asso-
ciated 95% confidence interval (CI).
RESULTS
The genotype frequencies at -160 promoter polymorphism
of E-cadherin in Korean gastric cancer cases and controls are
summarized in Table 1. The frequency of genotype C/C was
58.2%, C/A was 37.7%, and A/A was 4.1% in normal healthy
individuals, showing that C allele is more common than A
allele in Korean population. Interestingly, there was no sig-
nificant difference in the frequency of genotypes between con-
trol and gastric cancer patients, indicating no associations be-
tween the E-cadherin specific genotype and gastric cancer in
Korean ( 2 test, p=0.433). In addition, we could not find any
evidence for significant differences between intestinal- and
diffuse-type gastric cancers ( 2 test, p=0.196). Statistically,
there was also no significant difference between intestinal-type
gastric cancers and normal controls ( 2 test, p=0.142) and be-
tween diffuse-type and controls ( 2 test, p=0.989).
Genotype specific risks are shown in Table 2. The estimated
odds ratio of A/A to C/C genotype in gastric cancer was
1.066 (95% CI, 0.396-2.870) and the odd ratio in diffuse
histologic type was 0.944 (95% CI, 0.277-3.221). The odd
ratio of A allele to C allele in diffuse-type gastric cancer was
0.972 (95% CI, 0.650-1.452).
In addition, we found the T deletion polymorphism at -163
promoter of E-cadherin in 3 of 146 healthy individuals and 2
of 292 gastric cancer cases, respectively. 
DISCUSSION
Many common diseases in humans, especially cancer, are not
caused by one genetic variation within a single gene, but are
determined by complex interactions among multiple genes,
environmental and lifestyle factors. Genetic factors confer sus-
ceptibility or resistance to a disease and influence the severity
or progression of disease. Host factors, including polymor-
phism at the genes involved in tumorigenesis, may partly ex-
plain the difference in individual susceptibility of cancer occur-
rence (18). Single nucleotide polymorphisms (SNPs) are com-
mon DNA sequence variations among individuals. They pro-
mise to significantly advance our ability to understand and
treat human disease, including cancer. SNP profiles that are
characteristic of a variety of cancers will be established and pro-
vide fundamental understanding of many cancers, thus pro-
viding new therapeutic targets.
Development of malignant tumors is in part characterized
by the ability of a tumor cell to overcome cell-cell adhesion
and to invade surrounding tissue. E-cadherin, the main adhe-
sion molecule of epithelia, has been implicated in carcinogen-
esis because it is frequently lost in human epithelial cancers.
Recently, Li et al. (11) characterized a C/A polymorphism lo-
cated 160 upstream from the E-cadherin transcription start site
and found the A-allele to have reduced transcriptional activ-
ity of the C-allele in vitro. Thus, A-type promoter variant may
be regarded as a candidate cancer susceptibility polymorphism.
However, recent epidemiological studies failed to demonstrate
a correlation between the E-cadherin promoter variant and
breast (19) or colorectal cancer (20) or gastric cancer (15). In
the present study, there is no significant difference in the E-
cadherin -160 promoter genotype between normal healthy
individuals and gastric cancer patients (Table 1). Therefore,
it is likely that -160 promoter polymorphism of the E-cad-
herin gene may not be associated with risk for gastric cancer
among Koreans and that this allele variation should not be
a genetic marker to identify those individuals at higher risk
for gastric cancer.
Subject Total C/C C/A A/A 2 (df=2) p-value*
Control 146 85 (58.2%) 55 (37.7%) 6 (4.1%)
Gastric cancer
� 292 186 (63.7%) 92 (31.5%) 14 (4.8%) 1.674 0.433
Intestinal 165 111 (67.3%) 45 (27.3%) 9 (5.4%) 3.903 0.142
Diffuse 127 75 (59.1%) 47 (37.0%) 5 (3.9%) 0.021 0.989
*, p-value compared with normal control; 
� , intestinal- and diffuse-type.
Table 1. Genotype frequencies at -160 promoter polymorphic site of E-cadherin gene in healthy individuals and gastric cancer
patients
Subject
Genotype at -160 promoter of E-cadherin
C/A A/A A allele
Gastric cancer
� 0.764 (0.502-1.165)  1.066 (0.396-2.870)  0.869 (0.619-1.219) 
Intestinal 0.627 (0.386-1.017)  1.149 (0.394-3.352)  0.792 (0.538-1.167)
Diffuse 0.968 (0.589-1.594) 0.944 (0.277-3.221)  0.972 (0.650-1.452)
*, compared with common homozygote (C/C); 
� , intestinal- and diffuse-type. 
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Histologically, gastric cancer can be divided into intestinal
and diffuse subtypes according to the presence of glandular
structure formation by tumor cells. Interestingly, the genotyp-
ing data in the Italian group showed an association between
the promoter -160A allele and an increased risk of sporadic
diffuse-type gastric cancer (13). When we tried to determine
whether this polymorphism is important with respect to the
different histologic types of gastric cancer, we did not observe
any impact of E-cadherin genotype on histologic type, suggest-
ing that the presence of A allele in heterozygote C/A and ho-
mozygote A/A genotype did not affect the expression of E-cad-
herin protein. Several reasons may account for this discrepancy.
The influence of a susceptibility gene on disease risk may de-
pend on environmental factors and lifestyles. The different fre-
quency of H. pylori infection and different genetic background
between Italian and Korean populations may to some extent
explain the different risk estimates associated with the -160
variant. In addition, no direct correlation between mRNA ex-
pression and protein level by post-transcriptional regulation
may help us understand this discrepancy (21).
A genetic marker has to be relevant to the pathogenesis of
the disease in question and to occur at a sufficiently high fre-
quency to make its screening worthwhile. Since our data indi-
cate that -160 promoter polymorphism of the E-cadherin gene
is not sufficient to form the basis of a screening program for
Korean gastric cancer, addition of other relevant markers is
essential in refining this genetic strategy. In addition, a rigor-
ous case-control study on a large scale is mandatory to elucidate
the relationship between E-cadherin genotype and gastric
cancer risk.
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